Israel’s FIZE Medical (see here previously) has monitored over 4,000 patients at high risk of Acute Kidney Injury (AKI) since its launch last year at leading hospitals in the U.S. and Israel. In 2025 it plans to expand operations in Japan and Europe and enhance its production infrastructure in Israel and Vietnam.

https://www.calcalistech.com/ctechnews/article/s1f9axuhje